Ranibizumab (Lucentis) is an anti-VEGF therapy for retinal diseases like AMD, DME, and RVO. Learn about its mechanisms, clinical uses, benefits, side effects, and future research.
RVO
Staff Writer
World Eyecare Foundation staff writers are experienced eye care providers, researchers, academicians, industry leaders and practicing ophthalmologists and optometrist from around the world. Content may be generated by AI and is reviewed by the editorial team and specialists in the areas of publications.
World Eye Health Foundation’s mission is to help billions of people around the world to maintain healthy eyes.
© 2023 - 2024 World Eye Health Foundation • Privacy Policy • All Rights Reserved
